Implementation of Integrated Clinical Pharmacogenomics Testing at an Academic Medical Center
The Journal of Applied Laboratory Medicine · 2025
DOI: 10.1093/jalm/jfae128 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2025. Verfasst von Claire E Knezevic und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Hauptthemen laut MEDLINE: Academic Medical Centers, Pharmacogenomic Testing, Pharmacogenetics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Pharmacogenomics has demonstrated benefits for clinical care, including a reduction in adverse events and cost savings. However, barriers in expanded implementation of pharmacogenomics testing include prolonged turnaround times and integration of results into the electronic health record with clinical decision support. A clinical workflow was developed and implemented to facilitate in-house result generation and incorporation into the electronic health record at a large academic medical center.
Methods
An 11-gene actionable pharmacogenomics panel was developed and validated using a QuantStudio 12K Flex platform. Allelic results were exported to a custom driver and rules engine, and result messages, which included a diplotype and predicted metabolic phenotype, were sent to the electronic health record; an electronic consultation (eConsult) service was integrated into the workflow. Postimplementation monitoring was performed to evaluate the frequency of actionable results and turnaround times.
Results
The actionable pharmacogenomics panel covered 39 alleles across 11 genes. Metabolic phenotypes were resulted alongside gene diplotypes, and clinician-facing phenotype summaries (Genomic Indicators) were presented in the electronic health record. Postimplementation, 8 clinical areas have utilized pharmacogenomics testing, with 56% of orders occurring in the outpatient setting; 22.1% of requests included at least one actionable pharmacogene, and 67% of orders were associated with a pre- or postresult electronic consultation. Mean turnaround time from sample collection to result was 4.6 days.
Conclusions
A pharmacogenomics pipeline was successfully operationalized at a quaternary academic medical center, with direct integration of results into the electronic health record, clinical decision support, and eConsult services.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Department of Pharmacology & Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Data Innovations, Colchester, VT, United States.
ORCID-Profile: Mark A Marzinke
Zitieren
APA
Knezevic, C. E., Stevenson, J. M., Merran, J., Snyder, I., Restorick, G., Waters, C., & Marzinke, M. A. (2025). Implementation of Integrated Clinical Pharmacogenomics Testing at an Academic Medical Center. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfae128
Vancouver
Knezevic CE, Stevenson JM, Merran J, Snyder I, Restorick G, Waters C, et al. Implementation of Integrated Clinical Pharmacogenomics Testing at an Academic Medical Center. The Journal of Applied Laboratory Medicine. 2025. doi:10.1093/jalm/jfae128
BibTeX
@article{Knezevic2025,
author = {Knezevic, Claire E and Stevenson, James M and Merran, Jonathan and Snyder, Isabel and Restorick, Grant and Waters, Christopher and Marzinke, Mark A},
title = {Implementation of Integrated Clinical Pharmacogenomics Testing at an Academic Medical Center},
journal = {The Journal of Applied Laboratory Medicine},
year = {2025},
doi = {10.1093/jalm/jfae128}
}
EUVIMED